Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ADL

Amdl (ADL)

Amdl,
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ADL
DateTimeSourceHeadlineSymbolCompany
03/31/20069:12PMPR Newswire (US)AMDL Reports Fiscal 2005 Financial ResultsAMEX:ADLAmdl,
03/23/20064:20PMPR Newswire (US)AMDL CEO Gary Dreher Interviewed by World Talk Radio on Status of China AcquisitionsAMEX:ADLAmdl,
02/27/20065:00AMPR Newswire (US)German Researchers Detail Efficacy of AMDL's DR-70 Cancer Test as Tumor Marker for Ovarian CarcinomaAMEX:ADLAmdl,
01/31/20065:00AMPR Newswire (US)AMDL Signs Memorandum of Understanding for Clinical Trials in Taiwan for Its Combination Immunogene Therapy to Battle CancerAMEX:ADLAmdl,
01/19/20065:00AMPR Newswire (US)AMDL Announces Trip to China Relating to Purchase of Two Chinese Pharmaceutical FirmsAMEX:ADLAmdl,
01/09/20065:00AMPR Newswire (US)AMDL Continuing Plan to Acquire Two Chinese Pharmaceutical FirmsAMEX:ADLAmdl,
12/15/20055:51PMPR Newswire (US)AMDL CEO Interviewed at CEOcast.comAMEX:ADLAmdl,
11/22/200512:34AMPR Newswire (US)AMDL Announces Letter of Intent to Acquire Two Chinese Pharmaceutical FirmsAMEX:ADLAmdl,
11/14/20057:48PMPR Newswire (US)AMDL Reports 2005 Third Quarter Financial ResultsAMEX:ADLAmdl,
09/21/20057:16PMPR Newswire (US)AMDL Receives AMEX NotificationAMEX:ADLAmdl,
08/30/20054:43PMPR Newswire (US)AMDL Announces Second Closing of Private OfferingAMEX:ADLAmdl,
08/18/20057:00PMPR Newswire (US)AMDL Announces Closing of Private OfferingAMEX:ADLAmdl,
08/15/20053:35PMPR Newswire (US)German Researchers Confirm the Clinical Validity of AMDL's DR-70(R) in Detecting and Monitoring Ovarian CancerAMEX:ADLAmdl,
08/05/200510:00PMPR Newswire (US)AMDL Reports 2005 Second Quarter Financial ResultsAMEX:ADLAmdl,
06/20/20056:00AMPR Newswire (US)Report on June 16, 2005 AMDL Meeting With U.S. Food and Drug AdministrationAMEX:ADLAmdl,
06/15/20056:00AMPR Newswire (US)AMDL To Meet With U.S. Food and Drug Administration in Response to the Recent Adjunctive SubmissionAMEX:ADLAmdl,
06/08/200511:28AMPR Newswire (US)AMDL Receives Food and Drug Administration Response to Recent SubmissionAMEX:ADLAmdl,
05/12/20057:53PMPR Newswire (US)AMDL Reports 2005 First Quarter Financial ResultsAMEX:ADLAmdl,
03/30/200511:00PMPR Newswire (US)AMDL Reports Fiscal 2004 Financial ResultsAMEX:ADLAmdl,
03/20/200510:00AMPR Newswire (US)AMDL, Inc., Retains Trent & CompanyAMEX:ADLAmdl,
01/06/20052:47PMPR Newswire (US)AMDL Files New Application With FDAAMEX:ADLAmdl,
12/17/20046:00AMPR Newswire (US)AMDL Announces Second Closing of Private OfferingAMEX:ADLAmdl,
12/08/20046:04PMPR Newswire (US)AMDL Announces First Closing of Private OfferingAMEX:ADLAmdl,
11/17/20046:00AMPR Newswire (US)German Researchers Publish Results on AMDL's DR-70(R) Cancer Test Showing High SensitivityAMEX:ADLAmdl,
11/15/200410:52PMPR Newswire (US)AMDL Reports 2004 Third Quarter Financial ResultsAMEX:ADLAmdl,
11/08/20046:00AMPR Newswire (US)AMDL, Inc. to Be Featured on Steve Crowley's American Scene on Business Talk Radio NetworkAMEX:ADLAmdl,
08/12/20047:00AMPR Newswire (US)AMDL Reports 2004 Second Quarter Financial ResultsAMEX:ADLAmdl,
07/26/20048:00AMPR Newswire (US)AMDL Terminates Wainwright AgreementAMEX:ADLAmdl,
06/21/20048:00AMPR Newswire (US)AMDL to Present at American Stock Exchange's Online Investor ConferenceAMEX:ADLAmdl,
06/01/20046:00AMPR Newswire (US)AMDL's Recent U.S. Patent for Immunogene Therapy for Cancer Details Development of 'Humanized Mouse' to Assist Subsequent HumanAMEX:ADLAmdl,
 Showing the most relevant articles for your search:AMEX:ADL